149 related articles for article (PubMed ID: 14976535)
1. Biological behavior of keratoacanthoma and squamous cell carcinoma: telomerase activity and COX-2 as potential markers.
Putti TC; Teh M; Lee YS
Mod Pathol; 2004 Apr; 17(4):468-75. PubMed ID: 14976535
[TBL] [Abstract][Full Text] [Related]
2. Expression of Cyclooxygenase-2 in Squamous Cell Carcinoma and Keratoacanthoma and its Clinical Significance.
Hua HK; Jin C; Yang LJ; Tao SQ; Zhu XH
Cell Biochem Biophys; 2015 Jun; 72(2):475-80. PubMed ID: 25575894
[TBL] [Abstract][Full Text] [Related]
3. Keratoacanthoma versus squamous cell carcinoma. An immunohistochemical reappraisal of p53 protein and proliferating cell nuclear antigen expression in keratoacanthoma-like tumors.
Cain CT; Niemann TH; Argenyi ZB
Am J Dermatopathol; 1995 Aug; 17(4):324-31. PubMed ID: 8600793
[TBL] [Abstract][Full Text] [Related]
4. Expression of cell cycle and apoptosis regulatory proteins in keratoacanthoma and squamous cell carcinoma.
Batinac T; Zamolo G; Coklo M; Hadzisejdic I; Stemberger C; Zauhar G
Pathol Res Pract; 2006; 202(8):599-607. PubMed ID: 16781827
[TBL] [Abstract][Full Text] [Related]
5. Expression of apoptotic and cell proliferation regulatory proteins in keratoacanthomas and squamous cell carcinomas of the skin.
Ribeiro D; Narikawa S; Marques ME
Pathol Res Pract; 2008; 204(2):97-104. PubMed ID: 18079070
[TBL] [Abstract][Full Text] [Related]
6. Mutant p53 oncogene expression in keratoacanthoma and squamous cell carcinoma.
Stephenson TJ; Royds J; Silcocks PB; Bleehen SS
Br J Dermatol; 1992 Dec; 127(6):566-70. PubMed ID: 1476915
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-2 expression and angiogenesis in squamous cell carcinoma of the skin and its precursors: a paired immunohistochemical study of 35 cases.
Nijsten T; Colpaert CG; Vermeulen PB; Harris AL; Van Marck E; Lambert J
Br J Dermatol; 2004 Oct; 151(4):837-45. PubMed ID: 15491425
[TBL] [Abstract][Full Text] [Related]
8. Trisomy 7 in keratoacanthoma and squamous cell carcinoma detected by fluorescence in-situ hybridization.
Cheville JC; Bromley C; Argenyi ZB
J Cutan Pathol; 1995 Dec; 22(6):546-50. PubMed ID: 8835173
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of nicotinamide N-methyltransferase in cutaneous keratoacanthoma and squamous cell carcinoma: an immunohistochemical study.
Sartini D; Pompei V; Lucarini G; Rubini C; Molinelli E; Brisigotti V; Salvolini E; Campanati A; Offidani A; Emanuelli M
J Eur Acad Dermatol Venereol; 2020 Mar; 34(3):e121-e123. PubMed ID: 31705831
[No Abstract] [Full Text] [Related]
10. p53 expression in pseudoepitheliomatous hyperplasia, keratoacanthoma, and squamous cell carcinoma of skin.
Lee YS; Teh M
Cancer; 1994 May; 73(9):2317-23. PubMed ID: 8168036
[TBL] [Abstract][Full Text] [Related]
11. PGP 9.5 expression in cutaneous keratoacanthomas and squamous cell carcinomas.
Mastoraki A; Ioannidis E; Patsouris E; Safioleas M; Aroni K
Arch Dermatol Res; 2009 Oct; 301(9):653-8. PubMed ID: 19488775
[TBL] [Abstract][Full Text] [Related]
12. Is keratoacanthoma a variant of squamous cell carcinoma. New insights into an old controversy ... soon?
LeBoit PE
Am J Dermatopathol; 1995 Aug; 17(4):319-20. PubMed ID: 8600791
[No Abstract] [Full Text] [Related]
13. Immunohistochemical staining for the differentiation of subungual keratoacanthoma from subungual squamous cell carcinoma.
Connolly M; Narayan S; Oxley J; de Berker DA
Clin Exp Dermatol; 2008 Aug; 33(5):625-8. PubMed ID: 18616725
[TBL] [Abstract][Full Text] [Related]
14. The role of p53, Ki-67 and laminin expression in the differential diagnosis of keratoacanthoma and well-differentiated SCC.
Turan G; Altun E; Aslan F; Kulahci O
Indian J Pathol Microbiol; 2019; 62(4):561-565. PubMed ID: 31611440
[TBL] [Abstract][Full Text] [Related]
15. Keratoacanthoma and Keratoacanthoma-Like Squamous Cell Carcinoma: Similar Morphology but Different Pathogenesis.
Watanabe IC; Magalhães RF; de Moraes AM; Stelini RF; Cintra GF; Metze K; Cintra ML
Medicine (Baltimore); 2015 Jun; 94(23):e934. PubMed ID: 26061320
[TBL] [Abstract][Full Text] [Related]
16. Squamous proliferations on the legs of women: Qualitative examination of histopathology, TP53 sequencing, and implications for diagnosis in a series of 30 cases.
Ko CJ; Glusac EJ; McNiff JM; Rodic N; Leffell DJ
J Am Acad Dermatol; 2017 Dec; 77(6):1126-1132.e1. PubMed ID: 28709693
[TBL] [Abstract][Full Text] [Related]
17. Keratoacanthoma Shares Driver Mutations with Cutaneous Squamous Cell Carcinoma.
Lim YH; Fisher JM; Bosenberg MW; Choate KA; Ko CJ
J Invest Dermatol; 2016 Aug; 136(8):1737-1741. PubMed ID: 27283355
[No Abstract] [Full Text] [Related]
18. Down-regulation of nitric oxide synthase-2 and cyclooxygenase-2 pathways by p53 in squamous cell carcinoma.
Gallo O; Schiavone N; Papucci L; Sardi I; Magnelli L; Franchi A; Masini E; Capaccioli S
Am J Pathol; 2003 Aug; 163(2):723-32. PubMed ID: 12875991
[TBL] [Abstract][Full Text] [Related]
19. Transformation-specific matrix metalloproteinases, MMP-7 and MMP-13, are present in epithelial cells of keratoacanthomas.
Kuivanen TT; Jeskanen L; Kyllönen L; Impola U; Saarialho-Kere UK
Mod Pathol; 2006 Sep; 19(9):1203-12. PubMed ID: 16699496
[TBL] [Abstract][Full Text] [Related]
20. 'Anti-metastatic' nm23 gene product expression in keratoacanthoma and squamous cell carcinoma.
Stephenson TJ; Royds JA; Bleehen SS; Silcocks PB; Rees RC
Dermatology; 1993; 187(2):95-9. PubMed ID: 8358113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
